Early inflammation and immune response mRNAs in the brain of AD11 anti-NGF mice

Neurobiology of Aging

Volumn 32, Issue 6, 2011, Pages 1007-1022

  D'Onofrio, Mara ^a   Arisi, Ivan ^a   Brandi, Rossella ^a   Di Mambro, Alessandra ^a   Felsani, Armando ^b   Capsoni, Simona ^a   Cattaneo, Antonino ^a,c  

^a EUROPEAN BRAIN RESEARCH INSTITUTE   (Italy)

^b CNR   (Italy)

^c SCUOLA NORMALE SUPERIORE   (Italy)

Author keywords

AD11 mice; Alzheimer's disease; Early inflammation; Immune response; NGF

Indexed keywords

MESSENGER RNA; WNT PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CHOLINERGIC SYSTEM; CONTROLLED STUDY; FOREBRAIN; GENE EXPRESSION PROFILING; HIPPOCAMPUS; IMMUNE RESPONSE; INFLAMMATION; MOUSE; NERVE DEGENERATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

AGE FACTORS; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; ANTIBODIES; BRAIN; CHOLINE O-ACETYLTRANSFERASE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; INFLAMMATION; MICE; MICE, TRANSGENIC; NERVE GROWTH FACTOR; NERVE GROWTH FACTORS; NEURODEGENERATIVE DISEASES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, CHOLINERGIC; RNA, MESSENGER; SIGNAL TRANSDUCTION; STATISTICS, NONPARAMETRIC; WNT PROTEINS;

EID: 79955967542     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2009.05.023     Document Type: Article

References (61)

1. Araki T., Milbrandt J. Ninjurin2, a novel homophilic adhesion molecule, is expressed in mature sensory and enteric neurons and promotes neurite outgrowth. J. Neurosci. 2000, 20:187-195.
2. Arevalo J.C., Chao M.V. Axonal growth: where neurotrophins meet Wnts. Curr. Opin. Cell Biol. 2005, 17:112-115.
3. Ataman B., Ashley J., Gorczyca M., Ramachandran P., Fouquet W., Sigrist S.J., Budnik V. Rapid activity-dependent modifications in synaptic structure and function require bidirectional Wnt signaling. Neuron 2008, 57:705-718.
4. Bartus R.T., Dean R.L., Beer B., Lippa A.S. The cholinergic hypothesis of geriatric memory dysfunction. Science 1982, 217:408-414.
5. Boland B., Kumar A., Lee S., Platt F.M., Wegiel J., Yu W.H., Nixon R.A. Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer's disease. J. Neurosci. 2008, 28:6926-6937.
6. Bons N., Rieger F., Prudhomme D., Fisher A., Krause K.H. Microcebus murinus: a useful primate model for human cerebral aging and Alzheimer's disease?. Genes Brain Behav. 2006, 5:120-130.
7. Boulanger L.M., Shatz C.J. Immune signalling in neural development, synaptic plasticity and disease. Nat. Rev. Neurosci. 2004, 5:521-531.
8. Bruno M.A., Cuello A.C. Activity-dependent release of precursor nerve growth factor, conversion to mature nerve growth factor, and its degradation by a protease cascade. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:6735-6740.
9. Buxbaum J.N., Ye Z., Reixach N., Friske L., Levy C., Das P., Golde T., Masliah E., Roberts A.R., Bartfai T. Transthyretin protects Alzheimer's mice from the behavioral and biochemical effects of Abeta toxicity. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:2681-2686.
10. Capsoni S., Cattaneo A. On the molecular basis linking Nerve Growth Factor (NGF) to Alzheimer's disease. Cell. Mol. Neurobiol. 2006, 26:619-633.
11. Capsoni S., Giannotta S., Cattaneo A. Beta-amyloid plaques in a model for sporadic Alzheimer's disease based on transgenic anti-nerve growth factor antibodies. Mol. Cell. Neurosci. 2002, 21:15-28.
12. Capsoni S., Giannotta S., Cattaneo A. Early events of Alzheimer-like neurodegeneration in anti-nerve growth factor transgenic mice. Brain Aging 2002, 2:24-43.
13. Capsoni S., Ugolini G., Comparini A., Ruberti F., Berardi N., Cattaneo A. Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:6826-6831.
14. Caricasole A., Copani A., Caruso A., Caraci F., Iacovelli L., Sortino M.A., Terstappen G.C., Nicoletti F. The Wnt pathway, cell-cycle activation and beta-amyloid: novel therapeutic strategies in Alzheimer's disease?. Trends Pharmacol. Sci. 2003, 24:233-238.
15. Castano E.M., Roher A.E., Esh C.L., Kokjohn T.A., Beach T. Comparative proteomics of cerebrospinal fluid in neuropathologically-confirmed Alzheimer's disease and non-demented elderly subjects. Neurol. Res. 2006, 28:155-163.
16. Cattaneo A., Capsoni S., Paoletti F. Towards non invasive nerve growth factor therapies for Alzheimer's disease. J. Alzheimers Dis. 2008, 15:255-283.
17. Cattaneo A., Rapposelli B., Calissano P. Three distinct types of monoclonal antibodies after long-term immunization of rats with mouse nerve growth factor. J. Neurochem. 1988, 50:1003-1010.
18. Cerpa W., Godoy J.A., Alfaro I., Farias G.G., Metcalfe M.J., Fuentealba R., Bonansco C., Inestrosa N.C. Wnt-7a modulates the synaptic vesicle cycle and synaptic transmission in hippocampal neurons. J. Biol. Chem. 2008, 283:5918-5927.
19. Ciani L., Salinas P.C. WNTs in the vertebrate nervous system: from patterning to neuronal connectivity. Nat. Rev. Neurosci. 2005, 6:351-362.
20. Costa R., Goncalves A., Saraiva M.J., Cardoso I. Transthyretin binding to A-Beta peptide-impact on A-Beta fibrillogenesis and toxicity. FEBS Lett. 2008, 582:936-942.
21. Counts S.E., Nadeem M., Wuu J., Ginsberg S.D., Saragovi H.U., Mufson E.J. Reduction of cortical TrkA but not p75(NTR) protein in early-stage Alzheimer's disease. Ann. Neurol. 2004, 56:520-531.
22. Counts S.E., Perez S.E., Ginsberg S.D., De Lacalle S., Mufson E.J. Galanin in Alzheimer disease. Mol. Interv. 2003, 3:137-156.
23. Covaceuszach S., Cassetta A., Konarev P.V., Gonfloni S., Rudolph R., Svergun D.I., Lamba D., Cattaneo A. Dissecting NGF interactions with TrkA and p75 receptors by structural and functional studies of an anti-NGF neutralizing antibody. J. Mol. Biol. 2008, 381:881-896.
24. Crowley C., Spencer S.D., Nishimura M.C., Chen K.S., Pitts-Meek S., Armanini M.P., Ling L.H., McMahon S.B., Shelton D.L., Levinson A.D., Phillips H.S. Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons. Cell 1994, 76:1001-1011.
25. D'Andrea M.R. Evidence linking neuronal cell death to autoimmunity in Alzheimer's disease. Brain Res. 2003, 982:19-30.
26. De Ferrari G.V., Inestrosa N.C. Wnt signaling function in Alzheimer's disease. Brain Res. Rev. 2000, 33:1-12.
27. De Ferrari G.V., Moon R.T. The ups and downs of Wnt signaling in prevalent neurological disorders. Oncogene 2006, 25:7545-7553.
28. De Rosa R., Garcia A.A., Braschi C., Capsoni S., Maffei L., Berardi N., Cattaneo A. Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:3811-3816.
29. Deane R., Zlokovic B.V. Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease. Curr. Alzheimer Res. 2007, 4:191-197.
30. Delacourte A. From physiopathology to treatment of Alzheimer's disease. Rev. Neurol. (Paris) 2006, 162:909-912.
31. Echeverria V., Berman D.E., Arancio O. Oligomers of beta-amyloid peptide inhibit BDNF-induced arc expression in cultured cortical Neurons. Curr. Alzheimer Res. 2007, 4:518-521.
32. Fahnestock M., Michalski B., Xu B., Coughlin M.D. The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease. Mol. Cell. Neurosci. 2001, 18:210-220.
33. Games D., Buttini M., Kobayashi D., Schenk D., Seubert P. Mice as models: transgenic approaches and Alzheimer's disease. J. Alzheimers Dis. 2006, 9:133-149.
34. Goddard C.A., Butts D.A., Shatz C.J. Regulation of CNS synapses by neuronal MHC class I. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:6828-6833.
35. Hansen K., Wagner B., Hamel W., Schweizer M., Haag F., Westphal M., Lamszus K. Autophagic cell death induced by TrkA receptor activation in human glioblastoma cells. J. Neurochem. 2007, 103:259-275.
36. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297:353-356.
37. Huang Y.Z., Pan E., Xiong Z.Q., McNamara J.O. Zinc-mediated transactivation of TrkB potentiates the hippocampal mossy fiber-CA3 pyramid synapse. Neuron 2008, 57:546-558.
38. Inestrosa N.C., Varela-Nallar L., Grabowski C.P., Colombres M. Synaptotoxicity in Alzheimer's disease: the Wnt signaling pathway as a molecular target. IUBMB Life 2007, 59:316-321.
39. Lacor P.N., Buniel M.C., Chang L., Fernandez S.J., Gong Y., Viola K.L., Lambert M.P., Velasco P.T., Bigio E.H., Finch C.E., Krafft G.A., Klein W.L. Synaptic targeting by Alzheimer's-related amyloid beta oligomers. J. Neurosci. 2004, 24:10191-10200.
40. Lee J.A., Gao F.B. Regulation of Abeta pathology by beclin 1: a protective role for autophagy?. J. Clin. Invest. 2008, 118:2015-2018.
41. Mufson E.J., Counts S.E., Perez S.E., Binder L. Galanin plasticity in the cholinergic basal forebrain in Alzheimer's disease and transgenic mice. Neuropeptides 2005, 39:233-237.
42. Nagase T., Ito K.I., Kato K., Kaneko K., Kohda K., Matsumoto M., Hoshino A., Inoue T., Fujii S., Kato H., Mikoshiba K. Long-term potentiation and long-term depression in hippocampal CA1 neurons of mice lacking the IP(3) type 1 receptor. Neuroscience 2003, 117:821-830.
43. Oddo S., Caccamo A., Shepherd J.D., Murphy M.P., Golde T.E., Kayed R., Metherate R., Mattson M.P., Akbari Y., LaFerla F.M. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 2003, 39:409-421.
44. Origlia N., Capsoni S., Domenici L., Cattaneo A. Time window in cholinomimetic ability to rescue long-term potentiation in neurodegenerating anti-nerve growth factor mice. J. Alzheimers Dis. 2006, 9:59-68.
45. Paoletti F., Konarev P.V., Covaceuszach S., Schwarz E., Cattaneo A., Lamba D., Svergun D.I. Structural and functional properties of mouse proNGF. Biochem. Soc. Trans. 2006, 34:605-606.
46. Paoletti F., Covaceuszach S., Konarev P.V., Gonfloni S., Malerba F., Schwarz E., Svergun D.I., Cattaneo A., Lamba D. Intrinsic structural disorder of mouse proNGF. Proteins 2009, 75:990-1009.
47. Parachikova A., Agadjanyan M.G., Cribbs D.H., Blurton-Jones M., Perreau V., Rogers J., Beach T.G., Cotman C.W. Inflammatory changes parallel the early stages of Alzheimer disease. Neurobiol. Aging 2007, 28:1821-1833.
48. Pesavento E., Capsoni S., Domenici L., Cattaneo A. Acute cholinergic rescue of synaptic plasticity in the neurodegenerating cortex of anti-nerve-growth-factor mice. Eur. J. Neurosci. 2002, 15:1030-1036.
49. Piccioli P., Di Luzio A., Amann R., Schuligoi R., Surani M.A., Donnerer J., Cattaneo A. Neuroantibodies: ectopic expression of a recombinant anti-substance P antibody in the central nervous system of transgenic mice. Neuron 1995, 15:373-384.
50. Ray S., Britschgi M., Herbert C., Takeda-Uchimura Y., Boxer A., Blennow K., Friedman L.F., Galasko D.R., Jutel M., Karydas A., Kaye J.A., Leszek J., Miller B.L., Minthon L., Quinn J.F., Rabinovici G.D., Robinson W.H., Sabbagh M.N., So Y.T., Sparks D.L., Tabaton M., Tinklenberg J., Yesavage J.A., Tibshirani R., Wyss-Coray T. Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat. Med. 2007, 13:1359-1362.
51. Ruberti F., Bradbury A., Cattaneo A. Cloning and expression of an anti-nerve growth factor (NGF) antibody for studies using the neuroantibody approach. Cell. Mol. Neurobiol. 1993, 13:559-568.
52. Ruberti F., Capsoni S., Comparini A., Di Daniel E., Franzot J., Gonfloni S., Rossi G., Berardi N., Cattaneo A. Phenotypic knockout of nerve growth factor in adult transgenic mice reveals severe deficits in basal forebrain cholinergic neurons, cell death in the spleen, and skeletal muscle dystrophy. J. Neurosci. 2000, 20:2589-2601.
53. Ryu J.K., McLarnon J.G. A leaky blood-brain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimer's disease brain. J. Cell. Mol. Med. 2008, July 24 (Epub ahead of print).
54. Salehi A., Delcroix J.D., Mobley W.C. Traffic at the intersection of neurotrophic factor signaling and neurodegeneration. Trends Neurosci. 2003, 26:73-80.
55. Schindowski K., Belarbi K., Buee L. Neurotrophic factors in Alzheimer's disease: role of axonal transport. Genes Brain Behav. 2008, 7(Suppl. 1):43-56.
56. Sola E., Capsoni S., Rosato-Siri M., Cattaneo A., Cherubini E. Failure of nicotine-dependent enhancement of synaptic efficacy at Schaffer-collateral CA1 synapses of AD11 anti-nerve growth factor transgenic mice. Eur. J. Neurosci. 2006, 24:1252-1264.
57. Speese S.D., Budnik V. Wnts: up-and-coming at the synapse. Trends Neurosci. 2007, 30:268-275.
58. Stevens B., Allen N.J., Vazquez L.E., Howell G.R., Christopherson K.S., Nouri N., Micheva K.D., Mehalow A.K., Huberman A.D., Stafford B., Sher A., Litke A.M., Lambris J.D., Smith S.J., John S.W., Barres B.A. The classical complement cascade mediates CNS synapse elimination. Cell 2007, 131:1164-1178.
59. Takeda A. Movement of zinc and its functional significance in the brain. Brain Res. Rev. 2000, 34:137-148.
60. Tusher V.G., Tibshirani R., Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:5116-5121.
61. Vasto S., Candore G., Listi F., Balistreri C.R., Colonna-Romano G., Malavolta M., Lio D., Nuzzo D., Mocchegiani E., Di Bona D., Caruso C. Inflammation, genes and zinc in Alzheimer's disease. Brain Res. Rev. 2008, 58:96-105.